Colorectal Cancer Clinical Trial
Official title:
Use of Telehealth In-Home Messaging to Improve GI Endoscopy Completion Rates
Low endoscopy completion rates are a major problem in the VA, causing delay or failure to receive essential care, increased clinic wait times, lost capacity, increased costs, thus limiting endoscopic screening for colorectal cancer. This study tests whether an Interactive Voice Response (IVR) messaging system is equally effective in promoting the completion of flexible sigmoidoscopy and colonoscopy as usual clinical care practices that include phone calls from nurses to patients prior to preparation and procedures. Previous studies have examined the role of scheduling facilitation or patient adherence on endoscopy completion and the use of IVR technology to enhance patient adherence in other medical contexts. This is the first study, however, to evaluate the use of IVR for endoscopy completion and the first to compare it to the effectiveness of phone calls from nurses prior to an endoscopy appointment.
Background:
Low endoscopy completion rates are a major problem nationwide and in the VA. For clinics,
delays or failure to complete exams can cause clinic inefficiencies, such as increased wait
times for needed procedures, lost capacity, and increased costs. For patients, delays reduce
the chance for recommended timely screening consistent with practice guidelines and for
diagnostic tests, can cause significant anxiety, delayed treatment and possibly poorer
prognosis. This study tests whether an Interactive Voice Response (IVR) messaging system is
equally effective in motivating patients to complete a flexible sigmoidoscopy or colonoscopy
as usual clinical care practices, which include reminder phone calls from clinic nurses. This
is the first study to evaluate the use of IVR for endoscopy completion and the first to
compare it to the effectiveness of phone calls from nurses prior to an endoscopy appointment.
Objectives:
The primary set of objectives was to test whether IVR messaging was equivalent to clinic
usual care (UC) practices in motivating patients to attend a scheduled flexible sigmoidoscopy
or colonoscopy appointment and to adequately prepare for the exam. Secondary objectives
included comparing patient satisfaction with UC and IVR phone calls and assessing if IVR or
UC was more effective for sub-groups that may have more difficulty with preparation,
including those with poor physical and mental functioning, health literacy, social support
and trust in physicians and those with spinal cord injury, paraplegia, PTSD, or with little
intention to be tested for colorectal cancer in the future.
Methods:
This was a stratified 3-arm randomized controlled trial among patients with upcoming flexible
sigmoidoscopy or colonoscopy appointments. All patients who had a colonoscopy or flexible
sigmoidoscopy appointment scheduled from August 20, 2007 through October 31, 2008 were
assessed for inclusion in this study. Patients were not considered eligible if, based on a
medical record review prior to randomization, they had unreliable means of receiving the
intervention or the intervention would have provided inappropriate or inaccurate information.
The three study arms included: 1) UC (nurse phone call 7 days prior to the procedure); 2)
IVR7 (call from IVR system 7 days prior to procedure); and, 3) IVR3 (call from IVR system 3
days prior to procedure). One week after the initial appointment self-administered surveys
were sent to all participants to assess satisfaction with reminder/motivation calls.
Appointment and gastrointestinal (GI) procedure data were extracted from medical record files
to assess study outcomes. The principal outcome measures were (1) attendance at the scheduled
endoscopy appointment; (2) adequate preparation for the exam; (3) patient satisfaction with
reminder/motivation telephone calls.
Status:
Complete
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |